BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16882531)

  • 1. Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes.
    Li WF; Pan MH; Chung MC; Ho CK; Chuang HY
    Environ Health Perspect; 2006 Aug; 114(8):1233-6. PubMed ID: 16882531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.
    Kamal M; Fathy MM; Taher E; Hasan M; Tolba M
    Ann Saudi Med; 2011; 31(5):481-7. PubMed ID: 21911985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 1 status in the Thai population.
    Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
    J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides.
    Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.
    Drescher O; Dewailly E; Diorio C; Ouellet N; Sidi EA; Abdous B; Valera B; Ayotte P
    J Expo Sci Environ Epidemiol; 2014 Nov; 24(6):608-14. PubMed ID: 24448003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
    Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lead, cadmium and mercury with paraoxonase 1 activity and malondialdehyde in a general population in Southern Brazil.
    Almeida Lopes ACB; Urbano MR; Souza-Nogueira A; Oliveira-Paula GH; Michelin AP; Carvalho MFH; Camargo AEI; Peixe TS; Cabrera MAS; Paoliello MMB
    Environ Res; 2017 Jul; 156():674-682. PubMed ID: 28477577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
    Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
    Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
    Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
    Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
    Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
    AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
    Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic associations and serum paraoxonase levels with atherosclerosis in western Iranian patients.
    Shahsavari G; Nouryazdan N; Adibhesami G; Birjandi M
    Mol Biol Rep; 2020 Jul; 47(7):5137-5144. PubMed ID: 32567023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase activity and genetic polymorphisms in northern Han Chinese workers exposed to organophosphate pesticides.
    Zhang X; Sui H; Li H; Zheng J; Wang F; Li B; Zhang Y
    Exp Biol Med (Maywood); 2014 Feb; 239(2):232-9. PubMed ID: 24326413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.
    Zaragoza-García O; Guzmán-Guzmán IP; Moreno-Godínez ME; Navarro-Zarza JE; Antonio-Vejar V; Ramírez M; Parra-Rojas I
    Clin Rheumatol; 2021 Feb; 40(2):741-752. PubMed ID: 32556934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis.
    Bayrak A; Bayrak T; Tokgözoglu SL; Volkan-Salanci B; Deniz A; Yavuz B; Alikasifoglu M; Demirpençe E
    J Atheroscler Thromb; 2012; 19(4):376-84. PubMed ID: 22188760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.